Miaomiao Xi Selected Research

3,4-dihydroxyphenyllactic acid

12/2021	[Corrigendum] Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
11/2017	Danshensu accelerates angiogenesis after myocardial infarction in rats and promotes the functions of endothelial progenitor cells through SDF-1α/CXCR4 axis.
7/2016	Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
1/2013	Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miaomiao Xi Research Topics

Disease

11	Myocardial Ischemia (Ischemic Heart Diseases) 12/2021 - 01/2013
10	Reperfusion Injury 12/2021 - 01/2013
9	Infarction (Infarctions) 02/2019 - 01/2013
6	Inflammation (Inflammations) 03/2020 - 12/2012
5	Ischemia 11/2017 - 01/2013
4	Myocardial Infarction 11/2017 - 06/2013
4	Diabetes Mellitus 12/2015 - 02/2008
3	Type 2 Diabetes Mellitus (MODY) 05/2017 - 12/2013
3	Diabetic Cardiomyopathies 01/2017 - 01/2015
3	Hyperglycemia 01/2017 - 01/2015
2	Brain Ischemia (Cerebral Ischemia) 01/2021 - 01/2016
2	Chronic Renal Insufficiency 05/2020 - 08/2015
2	Insulin Resistance 01/2020 - 12/2013
2	Wounds and Injuries (Trauma) 01/2020 - 12/2015
2	Hypoxia (Hypoxemia) 11/2017 - 01/2013
2	Neoplasms (Cancer) 11/2017 - 08/2017
2	Necrosis 11/2017 - 08/2017
2	Fibrosis (Cirrhosis) 04/2017 - 08/2015
2	Pain (Aches) 07/2015 - 12/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 01/2013
1	Papillomavirus Infections 01/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021
1	Angina Pectoris 01/2021
1	Cerebral Infarction 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Neuroinflammatory Diseases 02/2019
1	Brain Edema (Cerebral Edema) 02/2019
1	Ischemic Stroke 02/2019
1	Burns 11/2017
1	Stroke (Strokes) 01/2016
1	Rheumatic Diseases (Rheumatism) 07/2015
1	Wound Infection (Wound Infections) 12/2013
1	Inguinal Hernia (Direct Inguinal Hernia) 12/2013
1	Surgical Wound Infection 12/2013

Drug/Important Bio-Agent (IBA)

6	AntioxidantsIBA 02/2019 - 02/2008
4	3,4-dihydroxyphenyllactic acidIBA 12/2021 - 01/2013
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 06/2013
4	chikusetsu saponin IVaIBA 01/2020 - 07/2015
4	CytokinesIBA 02/2019 - 11/2013
4	SaponinsIBA 12/2015 - 02/2008
3	Proteins (Proteins, Gene)FDA Link 11/2017 - 08/2015
3	Superoxide DismutaseIBA 11/2017 - 02/2013
3	Malondialdehyde (Propanedial)IBA 11/2017 - 02/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 01/2015
3	lithospermate BIBA 01/2014 - 02/2013
2	ameroidIBA 01/2021 - 11/2018
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 05/2017
2	LDL CholesterolIBA 01/2021 - 05/2017
2	oxidized low density lipoproteinIBA 01/2021 - 05/2017
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 05/2017
2	EnzymesIBA 02/2019 - 11/2013
2	Pharmaceutical PreparationsIBA 11/2018 - 12/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 04/2017
2	Glucose (Dextrose)FDA LinkGeneric 12/2013 - 02/2013
2	MB Form Creatine KinaseIBA 06/2013 - 01/2013
1	CholesterolIBA 01/2021
1	buteinIBA 01/2021
1	tongxinluoIBA 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	LipidsIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	Volatile Oils (Essential Oils)IBA 01/2021
1	rheinIBA 05/2020
1	salvianolic acid BIBA 03/2020
1	Calcium-Calmodulin-Dependent Protein Kinase KinaseIBA 02/2019
1	Neuroprotective AgentsIBA 02/2019
1	Small Interfering RNA (siRNA)IBA 02/2019
1	ApelinIBA 02/2019
1	Thymic Stromal LymphopoietinIBA 01/2019
1	plerixafor FDA Link 11/2017
1	CXC ChemokinesIBA 11/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2017
1	Hydroxyproline (4 Hydroxyproline)IBA 11/2017
1	CreatineIBA 08/2017
1	Nonesterified Fatty Acids (NEFA)IBA 05/2017
1	hydroxysafflor yellow AIBA 04/2017
1	butinIBA 01/2017
1	FlavonoidsIBA 01/2017
1	GlycosidesIBA 01/2017
1	AdiponectinIBA 01/2016
1	Sirtuin 1IBA 12/2015
1	Galactose (Galactopyranose)FDA LinkGeneric 12/2015
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2015
1	shenkangIBA 08/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2015
1	Niacinamide (Nicotinamide)FDA LinkGeneric 07/2015
1	Streptozocin (Streptozotocin)FDA Link 07/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2015
1	Insulin (Novolin)FDA Link 07/2015
1	AcidsIBA 01/2014
1	PolyphenolsIBA 01/2014
1	Polypropylenes (Polypropylene)IBA 12/2013
1	Metformin (Glucophage)FDA LinkGeneric 12/2013

Therapy/Procedure

2	Ligation 11/2017 - 06/2013
1	Condoms (Condom) 01/2022
1	Aftercare (After-Treatment) 08/2015
1	Antibiotic Prophylaxis 12/2013
1	Herniorrhaphy 12/2013